ClinicalTrials.govpublic full text
Tipifarnib in Treating Young Patients With Refractory Leukemia
leukemia, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, relapsing chronic myelogenous leukemia, blastic phase chronic myelogenous leukemia, chronic myelogenous leukemia, bcr-abl1 positive, childhood acute promyelocytic leukemia (m3), acute undifferentiated leukemia, juvenile myelomonocytic leukemia, childhood chronic myelogenous leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 861791
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.